Scorpion Sting 🔥

Epidemiology and Etiology of Scorpion Envenomation

• Scorpion envenomation is a frequent and potentially life-threatening medical emergency in tropical and subtropical regions, with over $1.2$ million stings and $3250$ deaths globally per year.
• In India, the most affected regions include Maharashtra, Karnataka, Tamil Nadu, West Bengal, Madhya Pradesh, Puducherry, and Orissa.
• While $86$ scorpion species have been identified in India, the vast majority of toxic stings are attributed to the red scorpion (Mesobuthus tamulus) and the black scorpion (Palamneus swammerdami).
• Mesobuthus tamulus is the most lethal species in the Indian subcontinent, capable of causing fatal envenomation across all pediatric and adult age groups.
• The severity of a sting correlates directly with the species of scorpion, amount of venom injected, and the patient's body surface area, rendering young children exceptionally vulnerable.

Venom Composition and Toxicokinetics

• Scorpion venom is an intricate chemical mixture consisting of neurotoxins, oligopeptides, amino acids, hemolytic toxins, phospholipase A, phosphodiesterase, and hyaluronidase.
• Once injected subcutaneously, the venom exhibits a prolonged absorption phase, taking approximately $7-8$ hours to be completely absorbed into the systemic circulation.
• The peak concentration in the blood is achieved at $101\pm 8$ minutes, and the elimination half-life ranges from $4.2-13.4$ hours.

Pathophysiology

Ion Channel Modulation

• The primary toxicological mechanism involves the direct interaction of specific venom proteins ($\alpha$-toxins and $\beta$-toxins) with excitable neuronal ion channels.
• The $\alpha$-toxin specifically targets site $3$ of the sodium channel, completely inactivating its closing potential without modifying the opening potential; this provokes massive depolarization, prolonged action potentials, cardiac arrhythmias, and paralysis.
• The $\beta$-toxin targets site $4$ of the sodium channel, directly inducing spastic or myoclonic muscular contractions.

The Autonomic Storm

• Ion channel derangements trigger an explosive, massive release of autonomic neurotransmitters (including acetylcholine, epinephrine, norepinephrine, glutamate, and aspartate), precipitating a clinical "autonomic storm".
• Sympathetic (Adrenergic) Stimulation: Results in a surge of catecholamines leading to tachycardia, severe hypertension, hyperthermia, diaphoresis, hyperglycemia, mydriasis, tachypnea, and tremors.
• Parasympathetic (Muscarinic) Stimulation: Drives opposing clinical findings such as severe bradycardia, hypotension, salivation, bronchorrhea, sweating, vomiting, urinary incontinence, and priapism.

Target Organ System Damage

• Cardiovascular System: Marked by intense catecholamine-induced vasospasm, extreme increases in myocardial oxygen demand, and altered sarcolemma permeability to calcium. This cascade culminates in severe myocardial injury, acute left ventricular (LV) dysfunction, and acute pulmonary edema (present in $3-24.5\mathrm{\%}$ of cases).
• Central Nervous System: Extreme hypertension and enormous catecholamine levels can precipitate hypertensive encephalopathy, cortical damage, cerebral infarctions, and seizures.
• Peripheral Nervous System: Presents as wild flailing, thrashing, abnormal oculomotor movements, and facial fasciculations.
• Other Systems: Microthrombi and altered clotting pathways can induce disseminated intravascular coagulation (DIC), while intense hemolysis can precipitate acute kidney injury. Direct venom toxicity can also manifest as acute pancreatitis and severe gastrointestinal distress.

Clinical Manifestations

• Clinical signs typically evolve rapidly, appearing within $30$ minutes to $6$ hours, and spontaneously subside over $24-48$ hours.
• Local Features: Intense, non-progressive local pain at the sting site accompanied by paresthesia, without the massive progressive swelling characteristic of snakebites.
• Cholinergic Phase ($0-4$ hours): The earliest systemic manifestation, lasting $6-13$ hours, defined by salivation, vomiting, profound diaphoresis, priapism, shivering, severe bradycardia, and hypotension.
• Adrenergic Phase ($4-48$ hours): The predominant life-threatening phase, featuring significant tachycardia, hypertension (in $15-45\mathrm{\%}$ of patients), LV dysfunction, shock, and pulmonary edema (which may be either cardiogenic or non-cardiogenic).
• Recovery Phase ($48-72$ hours): Characterized by hypotension with warm extremities and good pulse volume, representing a state of temporary catecholamine depletion that does not require dopamine agonist therapy.

Diagnostic and Laboratory Evaluation

• Electrocardiography (ECG): An essential early screening tool for myocardial injury; classic findings include peaked T waves, QR prolongation, ST-segment elevation (in leads I and aVL), QTc prolongation, low voltage complexes, and left anterior hemiblock.
• Echocardiography: The gold standard for assessing the severity of cardiogenic shock, often revealing global left ventricular dysfunction, ventricular dilatation, and distinct regional wall motion abnormalities.
• Chest Radiography: Can identify early pulmonary edema within $3$ hours of the sting, manifesting as prominent hilar congestion, peripheral non-branching lines, and inter-lobular septal edema.
• Biochemical Profiling: Toxicity often induces elevated levels of serum amylase, liver enzymes, lactate dehydrogenase (LDH), and potassium; lipid profile analysis may demonstrate elevated free fatty acids alongside diminished cholesterol and triglycerides.

Emergency Management and Pharmacotherapy

Initial Stabilization and General Measures

• Patients exhibiting severe systemic envenomation (Grades II-IV) or developing complications absolutely mandate intensive care unit (ICU) admission and continuous hemodynamic monitoring.
• Strict vital sign monitoring (blood pressure, heart rate, respiratory rate) must be performed every $15-30$ minutes during the acute phase.
• Provide immediate supplemental oxygen and anticipate the need for positive pressure ventilation for impending respiratory failure or established cardiogenic shock.
• Local wound care should involve thorough cleansing of the sting site and localized pain management utilizing ice packs, oral NSAIDs, or local xylocaine infiltration.

Targeted Drug Therapy

• Prazosin: Recognized as the definitive physiological antidote for scorpion stings, this competitive $\alpha$-1 receptor antagonist drastically reduces sympathetic outflow and directly activates venom-inhibited potassium channels. It successfully lowers blood pressure by reducing both preload and afterload, while independently preventing myocardial injury via cyclic GMP accumulation. The exact dosage is a stat administration of $30$ $\mu$g/kg, repeated as clinically necessary based on autonomic signs.
• Scorpion Antivenom: The specific neutralizing agent in India is a lyophilized monovalent enzyme-refined immunoglobulin (produced by Haffkine Bio-Pharmaceuticals) that specifically targets Mesobuthus tamulus venom. One reconstituted mL neutralizes $1.0$ mg of venom. The standard protocol dictates an initial dose of $3$ vials ($30$ mL) administered intravenously, which is highly preferred over intramuscular injection due to lower systemic toxicity and a markedly reduced incidence of subsequent cardiogenic shock.
• Dobutamine: The inotrope of choice for treating envenomation-induced cardiogenic shock with hypotension; administered via infusion at $5-15$ $\mu$g/kg/min to increase myocardial contractility without elevating systemic vascular resistance or increasing left ventricular afterload.
• Vasodilators (Nitroglycerine / Nitroprusside): Reserved for patients presenting with predominant pulmonary edema and intact blood pressure; nitroglycerine is initiated at $1-4$ $\mu$g/kg/h to decrease pulmonary venous congestion and afterload.
• Atropine: Routine administration is largely contraindicated because it heavily impairs sweating (disrupting crucial temperature regulation) and can precipitate catastrophic hypertension, pulmonary edema, and shock. Its use is strictly limited to cases of profound, life-threatening bradycardia or high-degree AV block at a dose of $0.02$ mg/kg.

Prognosis and Disposition

• Historically, untreated severe scorpion envenomation carried a devastating case fatality rate of $25-30\mathrm{\%}$.
• The universal incorporation of Prazosin therapy has successfully curtailed the mortality rate to $<1\mathrm{\%}$.
• Factors directly associated with a poor clinical prognosis include very young patient age ($<6$ years), marked delay in the initiation of Prazosin therapy, and the onset of profound encephalopathy, intractable arrhythmias, or massive pulmonary edema.
• Discharge criteria mandate that the child is completely hemodynamically stable, maintains a perfectly normal sensorium, demonstrates full resolution of any respiratory distress, has warm and well-perfused extremities, and remains entirely free of secondary complications.